In human immunodeficiency virus (HIV)-infected individuals, the proportion of circulating mononuclear cells (PBMCs) which carry HIV provirus and the number of HIV proviral sequences per infected PBMC have been matters for conjecture. Using a double polymerase chain reaction which allows the detection of single molecules of provirus and a method of quantifying the provirus molecules, we have measured provirus frequencies in infected individuals down to a level of one molecule per 10' PBMCs. As a general rule, only a small proportion of PBMCs contain provirus (median value of samples from 12 patients, one per 8,000 cells), and most if not all of the infected cells carry a single provirus molecule. The frequency of provirus-carrying cells correlated positively both with the progression of the disease and with the success with which virus could be isolated from the same patients by cocultivation methods. Of seven asymptomatic (Centers for Disease Control stage H) patients, all but one contained one provirus molecule per 6,000 to 80,000 cells; of five Centers for Disease Control stage IV patients, all but one contained one provirus molecule per 700 to 3,300 cells. When considered in conjunction with estimates of the frequency of PBMCs that express viral RNA, our results suggest that either (i) the majority of provirus-containing cells are monocytes or (ii) most provirus-containing lymphocytes are transcriptionally inactive. We also present nucleotide sequence data derived directly from provirus present in vivo which we show is not marred by the in vitro selection of potential virus variants or by errors introduced by Taq polymerase. We argue from these data that, of the provirus present in infected individuals, the proportion which is defective is not high in the regions sequenced.
Human immunodeficiency virus (HIV) causes a chronic and eventually fatal disease in humans. The time course of the disease is slow and involves the persistence of virus infection in the face of a specific antiviral response by all arms of the immune system. On primary infection there is an initial viremia, which is followed rapidly by antibody production and viral clearance (1, 5, 7) . However, protective immunity is not established, and signs of active infection reappear after a variable period of time. Progression to the acquired immunodeficiency syndrome (AIDS) correlates with the reappearance of circulating viral proteins (7, 23) and pathological evidence of extensive viral infiltration in many parts of the body, such as brain, gut, spleen, lymph nodes, and lungs (24, 26, 30, 31) .
The mechanism by which HIV persists is unclear. It has been proposed that the extensive sequence variation seen in the env gene allows the virus to evade the immune response (8, 32) . Another possibility is that the virus evades the immune system by virtue of a low level of gene expression in some of the cells that it infects. Cells of the monocytemacrophage lineage are more resistant to the cytolytic effect of HIV infection in vitro than are T4 lymphocytes (6) . Cells of the former type are considered by many investigators to constitute the main reservoir of HIV infection and to be the means by which viral infection is disseminated to multiple sites in the body (11, 21, 28) . In support of this view, HIV can readily be isolated from macrophages. On the other hand, there is also evidence that virus expression in periph-* Corresponding author.
eral blood mononuclear cells (PBMCs) from AIDS patients can be low or absent for long periods of time (35) , and nonexpressing T4 lymphocytes can be identified after in vitro infection (4, 12) .
Little is known about the distribution of proviral DNA in cells of the peripheral circulation. Neither the number of infected cells, the number of copies of provirus per cell, nor the cell type which contributes most to the progression of the disease are known with any certainty. Clearly, it is of fundamental importance to establish these basic parameters of the disease. Previous attempts to measure the prevalence of provirus and the frequency of infected cells in PBMCs from infected individuals have been only moderately successful. Shaw et al. (30) detected HIV-specific sequences in only 1 of 22 samples of DNA extracted from PBMCs of AIDS and AIDS-related complex patients. The Southern blotting method used in this case allowed the detection of provirus molecules at a frequency of one per 200 or fewer cells, suggesting that the prevalence of provirus-carrying cells is usually lower than this. Ulrich et al. (34) titrated PBMCs from asymptomatic HIV-infected patients before attempts at isolation and found that the number of PBMCs required to obtain a positive result varied widely between individuals. One patient yielded a positive culture from only 100 cells, while most required 104 to 105 cells, and two remained negative even when 106 cells were used. Harper et al. (9) used in situ hybridization to measure the number of HIV-expressing cells in PBMCs from a similar group of symptomatic patients. Positive cells were seen in only half of the samples tested, and in these samples their frequency was HIV PROVIRAL COPY NUMBER 865 again very low (one cell in 104 to 105). While these estimates are in good agreement, each poses problems of interpretation (see Discussion). In a number of published studies, the polymerase chain reaction (PCR) has been used to detect HIV proviral DNA sequences in PBMCs from seropositive patients. A striking feature of the results obtained so far is the scarcity or apparent absence of viral DNA in a proportion of patients (3, 10, 13, 22) . None of these reports includes an assessment of the sensitivity of the method in terms of the minimum number of HIV molecules required to produce a positive signal. However, the results do suggest that the proportion of infected cells within the PBMC population may be extremely low in many cases.
Here we describe a modified PCR method with a sensitivity sufficient to detect a single molecule of target DNA. After a first PCR amplification with a pair of HIV-specific primers, a small proportion of the product was used as the template for a second round of PCR amplification using a second set of primers nested within the first pair. By 10 contains DNA markers (HaeIII digest of pTZ18R). Extra bands of higher molecular weight were seen when relatively large amounts of template were transferred to the second reaction. Such DNA constitutes the linear accumulation of DNA copied from an inner primer-binding site to the end of DNA molecules bounded by the outer primers. (C) Samples, each nominally containing 6.5 ag, were simultaneously assayed in the double PCR. Lanes: 1, carrier DNA (negative control); 2 through 12, nominal 6.5-ag samples; 13, 65-ag sample; 14, markers. than the env gene (89.3 and 90.6%, respectively, versus 85%). The nested sets of gag, pol, and env sequences that were used in the work described here were chosen to be as highly conserved as possible (Fig. 1) .
Reliable detection of single template molecules by double PCR. The double PCR overcomes the problem of limited amplification of a rare template sequence. Nested primers were used previously to amplify a single-copy human gene (20) . During the first set of cycles, occasional interactions between the primers and mismatched sequences present in the genomic or carrier DNA led to some amplification of sequences other than the intended target sequence. The internally nested second primer pair ensured that only the desired sequences were further amplified during the second set of cycles. To take an example, in the amplification of the gag sequence the first step with the outer primers generated a 455-base-pair (bp) fragment. This product is then further amplified by using the inner primers to give a shorter (248-bp) fragment. Other nested outer and inner primer pairs were used in the same way. The procedure allowed the unequivocal identification of product HIV-specific DNA by agarose gel electrophoresis with ethidium bromide staining (Fig. 2) .
Serial 10-fold dilutions of plasmid pBH10.R3 DNA were made in a solution of herring sperm DNA to obtain plasmid DNA concentrations ranging from 65 ng/ml to 65 ag/ml. When 10-,u samples from these dilutions, containing from 6.5 ng to 0.65 ag of plasmid, were amplified with the use of the outer gag primer pair, the lowest amount of starting material that gave a clearly visible band of the expected size (455 bp) was 65 fg (Fig. 2A) . Addition of more Taq polymerase and further heat cycling did not measurably improve the sensitivity of the reaction (data not shown). On further amplification with the inner gag primers, the expected 248-bp band was detected from as little as 6.5 ag of starting material (Fig. 2B) . The larger bands present in reactions which contained greater amounts of template were probably the result of copying DNA which was correctly amplified during the first reaction beyond the opposite internal primer site and on to the end of the template. Products of this type of reaction should accumulate linearly with cycle number rather than exponentially.
The mass of one copy of pBH10.R3, obtained by dividing the molecular weight of the 13-kbp double-stranded DNA molecule by Avogadro number, was 13 ag. Thus, the positive double PCR result with a nominal 6.5 ag of DNA (Fig.  2B) presumably represents a reaction which contained a single template molecule. If so, other samples taken from the same DNA dilution should contain no plasmid molecules. To test this, parallel replicate assays were carried out so that each reaction nominally contained 6.5 ag of pBH10.R3 DNA. The expectation was that plasmid molecules would be distributed to some but not all of the replicate reactions. In agreement with this expectation, some of the reactions gave a positive result while others gave a negative result (Fig. 2C) . The positive reactions gave bands of similar intensity, and the proportion of positive to negative reactions was similar when the same set of assays was performed on separate occasions. The negative control reactions (with 1 In general, the titration of cells and DNA gave very similar results, showing a similar prevalence of positive reactions at limiting dilution (Table 3 ). The similarity in the two sets of figures provides very strong evidence that in the patients tested there is approximately one copy of provirus per HIV-infected cell. The relatively small data sets do not justify a more precise interpretation than this. The efficiency of the method that was used to prepare DNA from the diluted cells is between 60 and 75% (see Materials and Methods). Correcting for this would only slightly increase the predicted numbers of infected cells. Nucleotide sequences of PCR products confirm the amplification of single molecules. As a further confirmation that single molecules of proviral DNA from PBMC DNA were being detected in the double PCR, amplified DNA was recovered from positive reactions obtained at the limiting dilutions and sequenced. It is known that proviruses with different nucleotide sequences may be present in a single isolation (26) . If so, and if the positive reactions were due to the amplification of several molecules, sequence ambiguities should be observed, with more than one base sometimes appearing at the same position. Furthermore, differences in sequence will in general not be observed between parallel PCR products from the same DNA sample. On the other hand, if the positive reactions were due to the amplification of single molecules, each should give an unambiguous sequence. Also, if more than one provirus sequence was present in a given blood sample, different sequences should be amplified in different parallel reactions.
Limiting-dilution PCR products from patients 75, 76, and 79, amplified with gag primers, were sequenced directly by using primer 883. In the case of patient 75, 13,000 cell equivalents of DNA were an,plified, in the case of patient 76, 25 ,000 cell equivalents were amplified, and in the case of patient 79, 1,000 and 2,000 cell equivalents were amplified. These dilutions gave a low frequency of positive reactions (Table 1) and hence, if our conclusions are correct, the probability was high that single molecules would be amplified. Each amplification product gave an unambiguous readable sequence of at least 175 bases. Five of the seven sequences are unique, with variation both between samples derived from different patients and between parallel amplification reactions originating from the same DNA preparation ( Table 4 ). The sequence differences showed a bias towards synonymous mutations, an indication of functional constraints on variation in this region consistent with that observed between published gag sequences (15) . As an 
a Deviations shown are from the consensus of the published sequences shown in Fig. 1 . The position indicated relates to the 5' end of the fragment, i.e., the 5' end of the inner gag primer (Fig. 1, primer 883) . Silent mutations are in boldface type.
b Positive reactions obtained after distributing a limiting dilution.
illustration of the results obtained, Fig. 4 shows a difference in sequence between two reactions (b and c) from the DNA of patient 79.
Finally, a positive amplification reaction obtained from 105 cell equivalents of DNA from patient 76 was sequenced. This larger amount of template DNA was likely to contain several copies of provirus, and this was confirmed by the discovery of two ambiguities in the sequence. At each of these sites two bands of similar intensity were seen rather than the expected single band. In summary, the absence of ambiguities and the observed variation between and within patient samples when limiting dilutions of PBMC DNA were (Fig. 1) These observations argue against the presence of a large proportion of inactive provirus in the PBMCs, but only with the assumption that the sites of inactivation are distributed through the genome at random. If instead they are confined to particular regions, such as the regulatory regions of the genome (tat, rev, nef, and the long terminal repeat), we would not have detected them in the course of this analysis. Also, gross disruptive rearrangements of the proviral DNA would usually not be detected by the PCR.
The possibility that much of the provirus population may be transcriptionally inactive is supported by the finding of latency after in vitro infection (4, 35) . Even if only a small proportion of ongoing virus production produces a latent infection in vivo, the proportion of latently infected cells may steadily increase as the infection progresses, since the cells infected with active virus are probably destroyed. Provirus may be integrated into the chromosome at a site at which its expression is prevented, or it may be transcriptionally inactive by virtue of being extrachromosomal. The question of proviral inactivation is currently under investigation.
Sequence Another approach is to amplify the proviral sequences which are present in DNA extracted from PBMCs by the PCR method and to isolate molecular clones of the amplified product for sequencing. This method is also liable to give misleading results. The Taq polymerase introduces an error in about 1 nucleotide in 9,000 (33) . This means, for example, that after 20 cycles of amplification, 20% of 200-bp strands and 68% of 1-kilobase strands will carry one or more errors. (The proportion of strands with no errors is {1 -(L12E)}N, where L is the effective length of the template in base pairs, E is the reciprocal error rate per nucleotide, and N is the number of cycles.) Thus, it will be difficult or impossible to decide, after cloning and sequencing single amplified molecules, which differences are original and which were introduced by the polymerase. The dilution and distribution method which we have described here overcomes all of these difficulties. Only if an error occurs in the first cycle of amplification is it likely to cause a problem of interpretation. In this case, the error affects one-quarter of the fully amplified product; errors that occur during the second and subsequent cycles affect progressively less of the product. First-cycle errors will occur only rarely, during 1 in 10 amplifications of a 500-bp sequence or 1 in 25 amplifications of a 200-bp sequence. Such errors will be detected as ambiguities. The frequency of reactions which show a sequencing ambiguity because more than one template molecule is present will usually be greater than this. From the Poisson distribution, when 50% of reactions are positive, about one-third of the positive reactions will contain two template molecules; when 25% are positive, about oneeighth of the positive reactions will contain two templates. The best practice would seem to be to disregard all reactions in which sequence ambiguities arise.
